Metronidazole elimination is preserved in the elderly

Area of Science:

• Pharmacokinetics
• Geriatric Medicine
• Drug Metabolism

Background:

• Metronidazole is a widely used antibiotic.
• Understanding its pharmacokinetics in elderly populations is crucial for safe and effective dosing.

Purpose of the Study:

• To compare the disposition of metronidazole and its metabolites in elderly and young adults.
• To determine if age affects metronidazole elimination and if dose adjustments are needed.

Main Methods:

• A pharmacokinetic study comparing 11 elderly (86 +/- 6 years) and 8 young (30 +/- 6 years) subjects.
• Measured plasma clearance, volume of distribution, half-life, and urinary excretion of metronidazole and its hydroxy metabolite.

Main Results:

• No significant differences in metronidazole plasma clearance, volume of distribution, or half-life between elderly and young groups.
• Elderly subjects showed a larger area under the plasma concentration-time curve and longer half-life for the hydroxy metabolite.
• Urinary recovery of metronidazole and metabolites was lower in the elderly (42%) compared to the young (87%).

Conclusions:

• The elimination of metronidazole is largely preserved in old age.
• Renal excretion of unchanged metronidazole and the hydroxy metabolite are the primary elimination pathways affected by aging.
• Age-related dose adjustments for metronidazole are not considered necessary.